288 related articles for article (PubMed ID: 29886828)
21. Therapeutic Potential of Small Activating RNAs (saRNAs) in Human Cancers.
Yoon S; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):604-610. PubMed ID: 29804529
[TBL] [Abstract][Full Text] [Related]
22. Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy.
Xia W; Li D; Wang G; Ni J; Zhuang J; Ha M; Wang J; Ye Y
Cancer Gene Ther; 2016 Oct; 23(10):333-340. PubMed ID: 27608773
[TBL] [Abstract][Full Text] [Related]
23. Development of Therapeutic dsP21-322 for Cancer Treatment.
Kang MR; Li G; Pan T; Xing JC; Li LC
Adv Exp Med Biol; 2017; 983():217-229. PubMed ID: 28639203
[TBL] [Abstract][Full Text] [Related]
24. Current Advances in Small Activating RNAs for Gene Therapy: Principles, Applications and Challenges.
Zhou LY; He ZY; Xu T; Wei YQ
Curr Gene Ther; 2018; 18(3):134-142. PubMed ID: 29921205
[TBL] [Abstract][Full Text] [Related]
25. Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments.
Ghanbarian H; Aghamiri S; Eftekhary M; Wagner N; Wagner KD
Cells; 2021 Mar; 10(3):. PubMed ID: 33800164
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC.
Cai Y; Lyu T; Li H; Liu C; Xie K; Xu L; Li W; Liu H; Zhu J; Lyu Y; Feng X; Lan T; Yang J; Wu H
J Exp Clin Cancer Res; 2022 Dec; 41(1):335. PubMed ID: 36471363
[TBL] [Abstract][Full Text] [Related]
27. Promoter-Targeted Small Activating RNAs Alter Nucleosome Positioning.
Wang B; Hu Y
Adv Exp Med Biol; 2017; 983():53-61. PubMed ID: 28639191
[TBL] [Abstract][Full Text] [Related]
28. Defining features and exploring chemical modifications to manipulate RNAa activity.
Place RF; Noonan EJ; Földes-Papp Z; Li LC
Curr Pharm Biotechnol; 2010 Aug; 11(5):518-26. PubMed ID: 20662764
[TBL] [Abstract][Full Text] [Related]
29. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
[TBL] [Abstract][Full Text] [Related]
30. Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.
Kosaka M; Kang MR; Yang G; Li LC
Nucleic Acid Ther; 2012 Oct; 22(5):335-43. PubMed ID: 22909100
[TBL] [Abstract][Full Text] [Related]
31. Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation.
Hu J; Chen Z; Xia D; Wu J; Xu H; Ye ZQ
Biochem J; 2012 Nov; 447(3):407-16. PubMed ID: 23035981
[TBL] [Abstract][Full Text] [Related]
32. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.
Li C; Jiang W; Hu Q; Li LC; Dong L; Chen R; Zhang Y; Tang Y; Thrasher JB; Liu CB; Li B
Oncotarget; 2016 Apr; 7(16):22893-910. PubMed ID: 27014974
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
34. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
[TBL] [Abstract][Full Text] [Related]
35. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
36. C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.
Huan H; Wen X; Chen X; Wu L; Liu W; Habib NA; Bie P; Xia F
PLoS One; 2016; 11(4):e0153117. PubMed ID: 27050434
[TBL] [Abstract][Full Text] [Related]
37. Small-Activating RNA Can Change Nucleosome Positioning in Human Fibroblasts.
Wang B; Sun J; Shi J; Guo Q; Tong X; Zhang J; Hu N; Hu Y
J Biomol Screen; 2016 Jul; 21(6):634-42. PubMed ID: 26993320
[TBL] [Abstract][Full Text] [Related]
38. Small activating RNA induced expression of VHL gene in renal cell carcinoma.
Kang MR; Park KH; Lee CW; Lee MY; Han SB; Li LC; Kang JS
Int J Biochem Cell Biol; 2018 Apr; 97():36-42. PubMed ID: 29425832
[TBL] [Abstract][Full Text] [Related]
39. Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation.
Wang X; Wang J; Huang V; Place RF; Li LC
Biochem J; 2012 May; 443(3):821-8. PubMed ID: 22339500
[TBL] [Abstract][Full Text] [Related]
40. Strategies for HCC target discovery.
Molina-Sánchez P; Lujambio A
Aging (Albany NY); 2017 Apr; 9(4):1088-1089. PubMed ID: 28455974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
